Recombinant IL17A (Vunakizumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL17A (Vunakizumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL17A (Vunakizumab Biosimilar) in samples from Human.
Catalog No. ABIN7488115
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL17A (Vunakizumab Biosimilar) antibody (ABIN7488115)
Target
IL17A (Vunakizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL17A (Vunakizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Vunakizumab Biosimilar - Anti-IL17A mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL17A (Vunakizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
SHR-1314
Vunakizumab is a recombinant humanized IgGκ monoclonal antibody binds to and neutralises the proinflammatory cytokine interleukin-17A (IL-17A). -
CAS-No
- 1792181-33-9
Target
-
You are here:
